Abstract
To determine whether a particular phenotype or antigen is preferentially related to monoclonal gammopathies of undetermined significance (MGUS). Bone marrow specimens from 56 patients with MGUS were stained immunocytochemically (ABC peroxidase) for CD38, CD56, CD9, CD10, CD19, CD20, CD22, and MB2. Specimens from patients recently diagnosed with multiple myeloma and reactive bone marrow samples were studied in parallel. CD38 was expressed on all plasma cells from all MGUS samples tested, while 36% were positive for CD56, CD9 and MB2 were both expressed strongly; CD20 was moderately expressed, and staining for CD10 and CD22 was uncommon. For these five B cell antigens there was no clear difference between their expression in MGUS and in multiple myeloma. A great difference was found for CD19: in MGUS this antigen was expressed on 2-91% of plasma cells (mean 35%) and 77% patients had > 10% positive plasma cells; in multiple myeloma its expression was low and only 12% patients had > 10% positive plasma cells. When these results were converted to numbers of CD19 positive plasma cells per 100 nucleated bone marrow cells, reactive bone marrow and MGUS specimens had a similar number of positive plasma cells. There was no correlation be...Continue Reading
References
Mar 1, 1992·Annals of Hematology·R LeoH Deicher
Jul 1, 1992·British Journal of Haematology·H F BarkerI M Franklin
Sep 1, 1990·American Journal of Clinical Pathology·M F DehouB van Camp
Feb 1, 1991·British Journal of Haematology·J F San MiguelF Casanova
Nov 1, 1991·British Journal of Haematology·I Van RietB Van Camp
Oct 1, 1991·British Journal of Haematology·S S WeinreichW P Zeijlemaker
May 1, 1991·British Journal of Haematology·M S HamiltonI M Franklin
Jan 1, 1990·Acta Haematologica·C ShimazakiB D Clarkson
Mar 8, 1990·The New England Journal of Medicine·J EpsteinX Y He
Feb 1, 1990·American Journal of Hematology·C S ChanG P Schechter
Oct 1, 1989·Cellular Immunology·N J Zeleznik-Le, R S Metzgar
Sep 1, 1988·American Journal of Hematology·D E JoshuaH Kronenberg
Jan 1, 1986·British Journal of Haematology·J F San MiguelA Lopez Borrasca
Nov 1, 1987·Mayo Clinic Proceedings·P R GreippR A Kyle
Feb 1, 1987·Journal of Clinical Pathology·P A HallA G Stansfeld
Jan 1, 1982·Journal of Clinical Pathology·J P SaleunJ F Morin
Jan 1, 1993·British Journal of Haematology·P SonneveldE E Vela
Jan 1, 1993·Mayo Clinic Proceedings·R A Kyle
Jan 1, 1987·Immunology Today·H Zola
Citations
Jan 22, 2002·Cancer Genetics and Cytogenetics·Elisabet LloverasSoledad Woessner
Nov 3, 1998·Cancer Genetics and Cytogenetics·Y K KeungV Tonk
Jul 1, 1995·British Journal of Haematology·M ZandeckiT Facon
May 1, 1996·Somatic Cell and Molecular Genetics·R WangC C Liew
May 24, 2005·The Journal of Dermatology·Makiko Kagaya, Hiroyuki Takahashi
Mar 6, 2010·British Journal of Haematology·Karthick R M RajaRoman Hajek
Jun 10, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jesús F San MiguelAlberto Orfao
Sep 19, 2007·Arthritis Research & Therapy·Gyorgy CsakoFrederick W Miller
Apr 22, 2014·Leukemia Research·Gang AnLugui Qiu
Dec 12, 2007·Best Practice & Research. Clinical Haematology·Hervé Avet-Loiseau
Jan 8, 2000·Hematology/oncology Clinics of North America·T E Witzig
Jan 10, 2018·Cytometry. Part B, Clinical Cytometry·Sarika GuptaCarol J Holman
Sep 5, 2008·Current Protocols in Cytometry·Andy C Rawstron
Aug 3, 2020·Current Opinion in Oncology·David BeauvaisIbrahim Yakoub-Agha
Dec 22, 2016·Oncoimmunology·Djordje AtanackovicTim Luetkens
Jul 28, 2020·International Journal of Molecular Sciences·Hanley N Abramson
Nov 20, 2019·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Dominik F DraxlerMartin Willheim
Sep 8, 2019·Cellular Immunology·Daniel FeinbergYubin Kang
Apr 12, 2002·The American Journal of Pathology·Scott A Ely, Daniel M Knowles
May 19, 2001·Blood Cells, Molecules & Diseases·M LimaB Justiça